医学的治療における使用のための３－β－ヒドロキシ－５－α－プレグナン－２０－オン

Title:

医学的治療における使用のための３－β－ヒドロキシ－５－α－プレグナン－２０－オン

Document Type and Number:

Japanese Patent JP7179739

Kind Code:

B2

Abstract:

The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of Tourette's syndrome, obsessive compulsive disorder and/or gambling disorder, as well as methods for treating said disorders and pharmaceutical compositions for use in treatment of said disorders.

More Like This:

WO/2000/024388	COMBINATION OF 5-AMINOSALICYLIC ACID AND A BUDESONIDE, 6-METHYL PREDNISOLONE OR PREDNISOLONE FOR TREATING INFLAMMATORY DISORDERS OF THE INTESTINAL TRACT
JP5785392	Progesterone antagonists and selective progesterone modulators in the treatment of excess uterine bleeding
JP6486900	Progesterone receptor antagonist dosage form

Inventors:

Beckstrom, Torbjorn

Application Number:

JP2019540059A

Publication Date:

November 29, 2022

Filing Date:

February 09, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Asalina Pharma Abbey

International Classes:

A61K31/57; A61K45/00; A61P25/14

Domestic Patent References:

JP2002506034A

Foreign References:

WO2001008670A2

Other References:

Progress in Neuro-Psychopharmacology & Biological Psychiatry,2009年,Vol.33,p.1161-1166
Brain Research,2003年,Vol.982,p.45-53

Attorney, Agent or Firm:

Yoshiyuki Inaba
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito

Previous Patent: JP7179738

Next Patent: SHEET MOLDING COMPOUND FOR LOW-PRESSURE MOLDING